Cepheid Overview
- Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
4,972
- Latest Deal Type
-
Grant
- Investors
-
1
Cepheid General Information
Description
Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company's technology offers rapid on-demand genetic, sexual health, SARS-CoV-2, virology, oncology and critical infectious disease testing options, thereby helping laboratories and hospitals in making faster clinical decisions as opposed to culture or batch-based PCR testing.
Contact Information
Website
www.cepheid.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Parent Company
Primary Office
- 904 Caribbean Drive
- Sunnyvale, CA 94089
- United States
+1 (888) 000-0000
Cepheid Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 22-Oct-2021 | Completed | Generating Revenue/Not Profitable | |||
| 9. Grant | 30-Jul-2021 | 0000 | Completed | Generating Revenue/Not Profitable | ||
| 8. Grant | 01-Sep-2020 | 000 | Completed | Generating Revenue/Not Profitable | ||
| 7. Grant | 01-Feb-2020 | 00.00 | Completed | Generating Revenue/Not Profitable | ||
| 6. Merger/Acquisition | 04-Nov-2016 | 000 | 000.00 | 000 | Completed | Generating Revenue/Not Profitable |
| 5. Grant | 13-Nov-2014 | 00.00 | 000.00 | Completed | Generating Revenue/Not Profitable | |
| 4. IPO | 21-Jun-2000 | 000.00 | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 06-Mar-2000 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC | 30-Nov-1998 | $8.2M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series B) | 01-Apr-1998 | $8.2M | $8.2M | Completed | Generating Revenue |
Cepheid Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company
Diagnostic Equipment
Sunnyvale, CA
4,972
As of 2022
000.00
0000000000
0-0000
illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000000000 000000000
Uppsala, Sweden
000
As of 0000
00000
00000000
00000
000000
aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000 000000000
Thousand Oaks, CA
00
As of 0000
000.00
00.00
0000-00-00
00000000
000.00
Add Comparison
Cepheid Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Q-linea | Formerly VC-backed | Uppsala, Sweden | 000 | 00000 | 00000000 | 00000 |
| 00000000 00 | Formerly VC-backed | Thousand Oaks, CA | 00 | 000.00 | 00000000 | 000.00 |
| 000000000 | Formerly PE-Backed | Billerica, MA | 000 | 00000 | 00000000 | 00000 |
| 0000000 0000000 | Corporate Backed or Acquired | Brea, CA | 00000 | 000000&0 | ||
| 00000 | Formerly VC-backed | Fremont, CA | 000 | 00000 | 00000000 | 00000 |
Cepheid Patents
Cepheid Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220298572-A1 | Compositions and methods for discriminating bacterial and viral infections in a human subject | Pending | 16-Mar-2021 | 0000000000 | |
| US-20220224259-A1 | Encoderless motor with improved quantization and methods of use and calibration | Pending | 13-Jan-2021 | 000000000 | 0 |
| US-20220253079-A1 | Thermal control device and methods utilizing temperature distribution modeling | Pending | 13-Jan-2021 | 00000000000 | |
| US-20220249771-A1 | Lossy mechatronic systems and methods of estimation | Pending | 13-Jan-2021 | 000000000 | |
| US-20220134338-A1 | Diagnostic assay system with replaceable processing modules and remote monitoring | Pending | 30-Oct-2020 | G01N35/00 |
Cepheid Executive Team (16)
Cepheid Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| John Bishop | Cepheid | Chairman & Chief Executive Officer | 000 0000 |
| Thomas Gutshall | Cepheid | Co-Founder & Chairman | 000 0000 |
Cepheid Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cepheid Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Advanced Technology Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Band of Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| CampVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Innogenetics | Corporation | Minority | 000 0000 | 000000 0 |
Cepheid Investments & Acquisitions (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 01-Mar-2021 | 0000000000 | Diagnostic Equipment | ||
| 0000000000 00 | 01-Oct-2014 | 000000000 | 0000 | Buildings and Property | 0000 0000 |
| 00000000 0000 | 03-Nov-2008 | 0000000000 | 00.000 | Diagnostic Equipment | |
| 0000000 00000 | 14-Feb-2007 | 0000000000 | 0000 | Diagnostic Equipment | 0000 0000 |
| Actigenics | 09-Aug-2006 | Merger/Acquisition | 00.000 | Biotechnology |
Cepheid Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| OncoMark | Diagnostic Equipment | Dublin, Ireland | 2007 |
| 00000000 000000000 | Diagnostic Equipment | Stretton, United Kingdom | 0000 |